Alnylam Pharmaceuticals
ALNY
#598
Rank
HK$328.15 B
Marketcap
HK$2,459
Share price
1.11%
Change (1 day)
33.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company